DOCSLIB.ORG

Empowering the Pharmacist with Telepharmacy Greg Janes, MBA

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Empowering the Pharmacist with Telepharmacy Greg Janes, MBA Empowering the Pharmacist with Telepharmacy Greg Janes, MBA June 2017 Disclosures Cardinal Health has a commercial interest in telepharmacy, but does not reference any commercial products in this presentation. The opinions and recommendations expressed by the presenter are their own, and are to be used for educational purposes only. Why telepharmacy? 1. Utilize technology to improve patient adherence 2. Enable access to a pharmacist in rural communities 3. Increase pharmacist outreach in urban areas The four types of telepharmacy INPATIENT OUTPATIENT Remote order Retail entry review telepharmacy Remote IV admixture counseling Need for alternative delivery Independent Rural Pharmacies 2003-2013 7,624 924 independent rural pharmacies closed 12.1 % decrease 490 2007-2009 rural communities lost their only 7.2% 6,700 pharmacy decrease Source: Update: Independently Owned Pharmacy Closures in Rural America, 2003-2013; RUPRI Center for Rural Health Policy Analysis, Rural Policy Brief June 2014; Fred Ullrich, BA; Keith J. Mueller, PhD Telepharmacy historical timeline 1942 Australia’s Royal Flying Doctor Service 2001 North Dakota first state to allow 2001 Community Health Association in Spokane, WA launches program 2002 NDSU study begins 2003 Alaska Native Medical Center program 2006 U.S. Navy begins telepharmacy North Dakota telepharmacy case study Study conducted from 2002 - 2008 Medication dispensing error rate for Information of the North telepharmacies Dakota Telepharmacy Program provided by North Dakota State University School of 81 Pharmacy telepharmacies <1% Compared to a national average of: ~1.7 % Result: Positive outcomes, mechanisms could be improved Source: The North Dakota Experience: Achieving High-Performance Health Care Through Rural Innovation And Cooperation. May 2008 North Dakota telepharmacy case study Information of the North Dakota Telepharmacy Program provided by North Dakota State University School of Pharmacy Source: The North Dakota Experience: Achieving High-Performance Health Care Through Rural Innovation And Cooperation. May 2008 Telepharmacy regulations, 2008 Source: Telepharmacy project expands across country; 9/12/2008; Dave Kolpack, Associated Press Telepharmacy regulations, 2016 Source: Quarles & Brady LLP analysis & report, July 2016 Why telepharmacy? 1. Utilize technology to improve patient adherence 2. Enable access to a pharmacist in rural communities 3. Increase pharmacist outreach in urban areas How big is the adherence problem? 187M 13% Americans take $290 billion 1+ prescriptions healthcare expenses directly related to non-adherence avoidable costs Sources: Osterberg, L., Blaschke, T. (2005). Adherence to medication. N Engl J Med, 353(5), 487-497; Thinking Outside the Pillbox, A System-wide Approach to Improving Patient Medication Adherence for Chronic Disease; A NEHI Research Brief – August 2009 “The Leaky Bucket” According to IMS Health: Out of every 50-70 48-66 25-30 15-20 are 100 new arrive at a are picked up are taken refilled as prescriptions pharmacy by the patient properly prescribed Source: IMS Health Data, March 2011 Frequent interactions with patients Patients visit their pharmacist more than any other healthcare provider Provider # visits Primary care physician 4 Other healthcare providers 9 Pharmacist 35 Source: Pharmacists as Influencers of Patient Adherence, August 21, 2014, Joseph Moose, PharmD, and Ashley Branham, PharmD, BCACP Patients desire convenience 95% patients filled initial prescriptions when offered at doctor’s office Source: New Prescription Medication Gaps: A Comprehensive Measure of Adherence to New Prescriptions; Harvard Business Review Vol 44 | Num 5 | Oct 2009. Why telepharmacy? 1. Utilize technology to improve patient adherence 2. Enable access to a pharmacist in rural communities 3. Increase pharmacist outreach in urban areas Definition of rural According to HRSA: “Rural” encompasses all population, housing, and territory not included within an urban area. Source: https://www.hrsa.gov/ruralhealth/aboutus/definition.html Rural is becoming more rural 19.3% 77% of total population lives rural counties considered in rural areas health professional shortage areas Source: The Crisis in Rural Primary Care; WWAMI Rural Health Research Center, Policy Brief April 2009 2010 Census Urban and Rural Classification and Urban Area Criteria, https://www.census.gov/geo/reference/ua/urban-rural-2010.html Creating patient relationships “Telepharmacy helps create a new patient-pharmacist relationship that wasn’t possible before.” - Angela Falk, Pharm.D. Rural telepharmacy next to a health clinic Interior of a rural telepharmacy Rural community pharmacy grand opening Shoshone Telepharmacy, December 2016 Rural telepharmacy revives Main Street BEFORE AFTER Economics of telepharmacy NORTH DAKOTA ILLINOIS Results of the 6-year study with Estimate for one pharmacy based 81 locations: on financial data: $26.5 million $640,000 in economic development annual economic impact 80-100 new jobs created Source: North Dakota Telepharmacy Project https://www.ndsu.edu/telepharmacy/; Rural Economic Technical Assistance Center (RETAC) in Macomb, IL; Economic impacts of a pharmacy for Deiterich, Illinois, June 2015 Why telepharmacy? 1. Utilize technology to improve patient adherence 2. Enable access to a pharmacist in rural communities 3. Increase pharmacist outreach in urban areas Access challenges in urban areas University of Illinois Chicago did a study looking at “pharmacy deserts” in Chicago: Over one million residents live in 1+ miles these areas in Chicago to nearest pharmacy Source: Source: ‘Pharmacy Deserts’ Are Prevalent In Chicago’s Predominantly Minority Communities, Raising Medication Access Concerns, Dima M. Qato, Martha L. Daviglus, Jocelyn Wilder, Todd Lee, Danya Qato and Bruce Lambert. Patients desire convenient access 75% patients would prefer to fill prescriptions where they see their doctor if given the choice Source: Patient Attitudes toward Point-of-Care Medication Dispensing in a Primary Care Office Setting. July 19-22, 2007 by Opinion Research Corporation on behalf of Purkinje. www.purkinje.com. Readmission rates are high A study in Oregon found that readmission rates were higher in rural areas than urban, but both are still high: 15.3% 14.7% Rural Urban Source: Lack of pharmacy access sends some patients back to the hospital; Oregon State University and Oregon Health & Science University, August 2016 Better Education + Better Access Better Outcomes Pediatric hospital telepharmacy Telepharmacy in a community health center In-clinic pharmacy providing 340B Telepharmacy in a FQHC Common Questions Software solutions Advantages • Live pharmacist interaction • Constant updates • Low initial costs • Better education Disadvantages • Can be limited hours • Live internet connection Hardware or AMDS solutions Advantages • Can be available 24 hours • No on-site staff needed Disadvantages • Cost-prohibitive • Limited formulary • Mechanical failure • Complicated Telepharmacy workflow New prescription arrives at 1 Pharmacy A A B Technician A fills, taking images 2 of the process Pharmacist B reviews images 3 to verify fill is accurate Rx Tech RPh Tech Patient picks up Rx at Pharmacy A and 4 Pharmacist B counsels Endless opportunities Workload Hospitals balancing Pharmacy Accessible deserts specialists FAQ Safety Fill Accuracy (staff & location) Internet Diversion outage Regulatory Considerations Telepharmacy regulations, 2016 Source: Quarles & Brady LLP analysis & report, July 2016 Regulations are fragmented • Different for each type of telepharmacy • Vary widely by state • Practice setting • Verification site location • Urban allowances States that have telepharmacy language can benefit from aligning their rules NABP currently has a task force to create model language Indiana House Bill 1540 (Telepharmacy) (3) Be located at least ten (10) miles from an existing retail pharmacy unless: (A) the applicant with the proposed remote dispensing facility demonstrates to the board how the proposed remote dispensing facility will promote public health; or (B) the pharmacy located less than ten (10) miles from the remote dispensing facility is part of a hospital or a physician clinic setting. A qualifying pharmacist may have this designation for only one (1) supervising pharmacy and for one (1) remote dispensing facility at a time. There must be at least one (1) pharmacist working at a remote dispensing facility for every six (6) pharmacist interns, licensed https://iga.in.gov/legislative/2017/bills/house/1540#digest-heading https://iga.in.gov/legislative/2017/bills/house/154pharmacy technicians,0#document-69db09e3 and pharmacy technicians in training at the supervising pharmacy and remote dispensing facility Indiana Statistics 60 pharmacy deserts 56k+ underserved patients 99 at-risk communities 233 cities with no pharmacy Why telepharmacy? 1.Utilize technology to improve patient adherence 2.Enable access to a pharmacist in rural communities 3.Increase pharmacist outreach in urban areas Questions? Greg Janes, MBA [email protected] (319) 774-1628 For updates and more information, visit telepharm.com/learn Typical regulations Pharmacy technician certification • Hours and/or years of experience Limits on number of remote sites or technicians Special rules around Controls Mileage restrictions Security requirements Technology requirements Signage in the telepharmacy location Telepharmacy regulation considerations Need is increasing every year • Physician Dispensing • Mail order Successful programs already in place Consider the present as well as the future Get ahead of the technology and legislators • Don't include technology requirements Steps to implementing regulations Look for statutory authority 1 • If no statutory authority, must engage legislature 2 Have Board Rules Committee draft rules 3 Board notices rules to the public 4 Public comment period 5 Administrative rules review process & approval 6 Implementation Tips to drafting regulations Look into what other states have for regulation Visit a retail telepharmacy location which is in operation Understand the landscape in your state Ensure statutes leave room for administrative rules.
Load more

Recommended publications
  • Clinical Pharmacy Specialist
    SAMPLE JOB DESCRIPTION Clinical Pharmacist Specialist I. JOB SUMMARY The Clinical Pharmacist Specialists are responsible and accountable for the provision of safe, effective, and prompt medication therapy. Through various assignments within the department, they provide support of centralized and decentralized medication-use systems as well as deliver optimal medication therapy to patients with a broad range of disease states. Clinical Pharmacist Specialists proficiently provide direct patient-centered care and integrated pharmacy operational services in a decentralized practice setting with physicians, nurses, and other hospital personnel. These clinicians are aligned with target interdisciplinary programs and specialty services to deliver medication therapy management within specialty patient care services and to ensure pharmaceutical care programs are appropriately integrated throughout the institution. In these clinical roles, Clinical Pharmacist Specialists participate in all necessary aspects of the medication-use system while providing comprehensive and individualized pharmaceutical care to the patients in their assigned areas. Pharmaceutical care services include but are not limited to assessing patient needs, incorporating age and disease specific characteristics into drug therapy and patient education, adjusting care according to patient response, and providing clinical interventions to detect, mitigate, and prevent medication adverse events. Clinical Pharmacist Specialists serve as departmental resources and liaisons to other
    [Show full text]
  • Patient Care Through Telepharmacy September 2016
    Patient Care through Telepharmacy September 2016 Gregory Janes Objectives 1. Describe why telepharmacy started and how it has evolved with technology 2. Explain how telepharmacy is being used to provide better patient care, especially in rural areas 3. Understand the current regulatory environment around the US and what states are doing with regulation Agenda ● Origins of Telepharmacy ● Why now? ● Telepharmacy process ● Regulatory environment ● Future Applications Telepharmacy Prescription verification CounselingPrescription & verification Education History Origins of Telepharmacy 1942 Australia’s Royal Flying Doctor Service 2001 U.S. has first state pass telepharmacy regulation 2003 Canada begins first telepharmacy service 2010 Hong Kong sees first videoconferencing consulting services US Telepharmacy Timeline 2001 North Dakota first state to allow 2001 Community Health Association in Spokane, WA launches program 2002 NDSU study begins 2003 Alaska Native Medical Center program 2006 U.S. Navy begins telepharmacy 2012 New generation begins in Iowa Question #1 What was the first US state to allow Telepharmacy? a) Alaska b) North Dakota c) South Dakota d) Hawaii Question #1 What was the first US state to allow Telepharmacy? a) Alaska b) North Dakota c) South Dakota d) Hawaii NDSU Telepharmacy Study Study from 2002-2008 ● 81 pharmacies ○ 53 retail and 28 hospital ● Rate of dispensing errors <1% ○ Compared to national average of ~2% ● Positive outcomes, mechanisms could be improved Source: The North Dakota Experience: Achieving High-Performance
    [Show full text]
  • Preventive Health Care
    PREVENTIVE HEALTH CARE DANA BARTLETT, BSN, MSN, MA, CSPI Dana Bartlett is a professional nurse and author. His clinical experience includes 16 years of ICU and ER experience and over 20 years of as a poison control center information specialist. Dana has published numerous CE and journal articles, written NCLEX material, written textbook chapters, and done editing and reviewing for publishers such as Elsevire, Lippincott, and Thieme. He has written widely on the subject of toxicology and was recently named a contributing editor, toxicology section, for Critical Care Nurse journal. He is currently employed at the Connecticut Poison Control Center and is actively involved in lecturing and mentoring nurses, emergency medical residents and pharmacy students. ABSTRACT Screening is an effective method for detecting and preventing acute and chronic diseases. In the United States healthcare tends to be provided after someone has become unwell and medical attention is sought. Poor health habits play a large part in the pathogenesis and progression of many common, chronic diseases. Conversely, healthy habits are very effective at preventing many diseases. The common causes of chronic disease and prevention are discussed with a primary focus on the role of health professionals to provide preventive healthcare and to educate patients to recognize risk factors and to avoid a chronic disease. nursece4less.com nursece4less.com nursece4less.com nursece4less.com 1 Policy Statement This activity has been planned and implemented in accordance with the policies of NurseCe4Less.com and the continuing nursing education requirements of the American Nurses Credentialing Center's Commission on Accreditation for registered nurses. It is the policy of NurseCe4Less.com to ensure objectivity, transparency, and best practice in clinical education for all continuing nursing education (CNE) activities.
    [Show full text]
  • Pharmacist-Physician Team Approach to Medication-Therapy
    Pharmacist-Physician Team Approach to Medication-Therapy Management of Hypertension The following is a synopsis of “Primary-Care-Based, Pharmacist-Physician Collaborative Medication-Therapy Management of Hypertension: A Randomized, Pragmatic Trial,” published online in June 2014 in Clinical Therapeutics. What is already known on this topic? found that the role of the pharmacist differed within each study; whereas some pharmacists independently initiated and High blood pressure, also known as hypertension, is a changed medication therapy, others recommended changes major risk factor for cardiovascular disease, the leading to physicians. Pharmacists were already involved in care in all cause of death for U.S. adults. Helping patients achieve but one study. blood pressure control can be difficult for some primary care providers (PCPs), and this challenge may increase with After reviewing the RCTs, the authors conducted a randomized the predicted shortage of PCPs in the United States by 2015. pragmatic trial to investigate the processes and outcomes that The potential shortage presents an opportunity to expand result from integrating a pharmacist-physician team model. the capacity of primary care through pharmacist-physician Participants were randomly selected to receive PharmD-PCP collaboration for medication-therapy management (MTM). MTM or usual care from their PCPs. The authors conducted MTM performed through a collaborative practice agreement the trial within a university-based internal medicine medical allows pharmacists to initiate and change medications. group where the collaborative PharmD-PCP MTM team Researchers have found positive outcomes associated included an internal medicine physician and two clinical with having a pharmacist on the care team; however, the pharmacists, both with a Doctor of Pharmacy degree, at least evidence is limited to only a few randomized controlled 1 year of pharmacy practice residency training, and more than trials (RCTs).
    [Show full text]
  • Medicare Modernization Act Final Guidelines
    MEDICARE MODERNIZATION ACT FINAL GUIDELINES -- FORMULARIES CMS Strategy for Affordable Access to Comprehensive Drug Coverage Guidelines for Reviewing Prescription Drug Plan Formularies and Procedures 1. Purpose of the Guidance This paper is final guidance on how CMS will review Medicare prescription drug benefit plans to assure that beneficiaries receive clinically appropriate medications at the lowest possible cost. Two key requirements in the Medicare Modernization Act (MMA) are to assure that drug plans provide access to medically necessary treatments for all and do not discriminate against any particular types of beneficiaries, and to encourage and support the use of approaches to drug benefit management that are proven and in widespread use in prescription drug plans today. The goal is for plans to provide high-quality cost-effective drug benefits by negotiating the best possible prices and using effective drug utilization management techniques. This goal can be achieved through a CMS drug benefit review strategy that facilitates appropriate beneficiary access to all medically necessary Part D covered drugs along with plan flexibility to develop efficient benefit designs, thus bringing drug benefit strategies that are already providing effective coverage to millions of seniors and people with a disability to the Medicare population. Our formulary review process focuses on three areas: 1. Pharmacy and Therapeutics (P&T) committees. CMS will require P&T committees to rely on widely-used best practices, reinforced by MMA standards. CMS oversight of these processes will assure that plan formularies are designed to provide appropriate, up-to-date access for beneficiaries and give plans the flexibility to offer benefit designs that provide affordable access to medically necessary drugs.
    [Show full text]
  • Oklahoma Primary Care Health Care Workforce Gap Analysis
    Oklahoma Primary Care Health Care Workforce Gap Analysis DRAFT Prepared by OSU Center for Rural Health OSU Center for Health Sciences Tulsa, Oklahoma June 2015 Table of Contents Table of Figures ..................................................................................................................................................... ii Tables........................................................................................................................................................................ iii Introduction ............................................................................................................................................................ 1 Background & Data Acquisition ...................................................................................................................... 2 Methodology ........................................................................................................................................................... 2 Primary Care Provider Supply ......................................................................................................................... 3 Primary Care Provider Demand ................................................................................................................... 10 Conclusions .......................................................................................................................................................... 12 Limitations ...........................................................................................................................................................
    [Show full text]
  • Primary Care Network Listing | Healthpartners
    DHS-6594C-ENG HealthPartners® Minnesota Senior Health Options (MSHO) (HMO SNP) Network April 2018 – September 2018 PRIMARY CARE NETWORK LISTING Minnesota Counties: Anoka, Benton, Carver, Chisago, Dakota, Hennepin, Ramsey, Scott, Sherburne, Stearns, Washington, Wright HealthPartners 8170 33rd Ave S. P.O. Box 1309 Minneapolis, MN 55440-1309 Member Services: 952-967-7029 or 1-888-820-4285 (TTY/TDD 711) Oct. 1 – Feb. 14 8 a.m. to 8 p.m. CT, seven days a week Feb. 15 – Sept. 30 8 a.m. to 8 p.m. CT, Monday – Friday healthpartners.com/msho HealthPartners is a health plan that contracts with both Medicare and the Minnesota Medical Assistance (Medicaid) program to provide benefits of both programs to enrollees. Enrollment in HealthPartners depends on contract renewal. HealthPartners MSHO Plan 16697_Print April 2018 H2422 108677 DHS Approved 1/25/2018 1-888-820-4285 Attention. If you need free help interpreting this document, call the above number. ያስተውሉ፡ ካለምንም ክፍያ ይህንን ዶኩመንት የሚተረጉምሎ አስተርጓሚ ከፈለጉ ከላይ ወደተጻፈው የስልክ ቁጥር ይደውሉ። مﻻحظة: إذا أردت مساعدة مجانية لترجمة هذه الوثيقة، اتصل على الرقم أعﻻه. သတိ။ ဤစာရြက္စာတမ္းအားအခမဲ့ဘာသာျပန္ေပးျခင္း အကူအညီလုုိအပ္ပါက၊ အထက္ပါဖုုန္းနံပါတ္ကုုိေခၚဆုုိပါ။ kMNt’sMKal’ . ebIG~k¨tUvkarCMnYyk~¬gkarbkE¨bäksarenHeday²tKit«f sUmehATUrs&BÍtamelxxagelI . 請注意，如果您需要免費協助傳譯這份文件，請撥打上面的電話號碼。 Attention. Si vous avez besoin d’une aide gratuite pour interpréter le présent document, veuillez appeler au numéro ci-dessus. Thov ua twb zoo nyeem. Yog hais tias koj xav tau kev pab txhais lus rau tsab ntaub ntawv no pub dawb, ces hu rau tus najnpawb xov tooj saum toj no.
    [Show full text]
  • Prescription Drug Benefit Administration Drug Formulary
    SECTION 8 PHARMACY Prescription Drug Benefit Administration Health Alliance administers pharmacy benefits in conjunction with OptumRx, a pharmacy benefit management (PBM) company. This function is coordinated by the Pharmacy Department at Health Alliance. Activities of this department include: Pharmacy network development and maintenance Third-party claims processor relations, contract development and management Manufacturer discount contracting Pharmacy and Therapeutics Committee (P&T) support Drug formulary coordination and management Utilization Management Department clinical support Medical Directors Committee and administrative support Quality Improvement Committee support Assistance in improving quality measures related to medications Pharmacy utilization reporting and physician support Customer Service and Claims Departments support Medicare Part D Formulary coordination and management Drug Formulary The Health Alliance drug formularies were created to assist in the management of ever-increasing costs of prescription medications. The use of formularies to provide physicians with a reference for cost-effective medical treatment has been used successfully in health insurance organizations throughout the country. Formularies were created under the guidance of physicians and pharmacists representing most specialties. The P&T Committee evaluates the need of patients, use of products and cost-effectiveness as factors to determine the formulary choices. In all cases, available bioequivalence data and therapeutic activity are considered. The P&T Committee meets on a regular basis to evaluate the changing needs of physicians and patients. We urge you to provide recommendations for improvement of the drug formularies. It is our belief that the drug formularies can enhance your ability to provide quality, cost-effective care to your Health Alliance patients. The use of generic and over-the-counter (OTC) products is highly recommended when applicable.
    [Show full text]
  • ASHP Statement on Pharmaceutical Care
    Medication Therapy and Patient Care: Organization and Delivery of Services–Statements 331 ASHP Statement on Pharmaceutical Care The purpose of this statement is to assist pharmacists in under- Care. Central to the concept of care is caring, a personal standing pharmaceutical care. Such understanding must pre- concern for the well-being of another person. Overall cede efforts to implement pharmaceutical care, which ASHP patient care consists of integrated domains of care including believes merit the highest priority in all practice settings. (among others) medical care, nursing care, and pharmaceu- Possibly the earliest published use of the term pharma- tical care. Health professionals in each of these disciplines ceutical care was by Brodie in the context of thoughts about possess unique expertise and must cooperate in the patient’s drug use control and medication-related services.1,2 It is a overall care. At times, they share in the execution of the various term that has been widely used and a concept about which types of care (including pharmaceutical care). To pharma- much has been written and discussed in the pharmacy pro- ceutical care, however, the pharmacist contributes unique fession, especially since the publication of a paper by Hepler knowledge and skills to ensure optimal outcomes from the and Strand in 1990.3–5 ASHP has formally endorsed the con- use of medications. cept.6 With varying terminology and nuances, the concept At the heart of any type of patient care, there exists a has also been acknowledged by other national pharmacy or- one-to-one relationship between a caregiver and a patient.
    [Show full text]
  • Intensive Care Units (ICU): the Clinical Pharmacist Role to Improve Clinical Outcomes and Reduce Mortality Rate- an Undeniable Function
    Open Access Journal of Clinical Intensive Care and Medicine Review Article Intensive Care Units (ICU): The clinical pharmacist role to improve clinical ISSN 2639-6653 outcomes and reduce mortality rate- An undeniable function Luisetto M1* and Ghulam Rasool Mashori2 1Applied Pharmacologist, Hospital Pharmacist Manager 29121, Italy 2Professor & Director, Peoples University of Medcial & Health Sciences for Woman, Nawabshah, Pakistan *Address for Correspondence: Luisetto M, Applied Abstract Pharmacologist, Hospital Pharmacist Manager 29121, Italy, Email: [email protected] Observing relevant biomedical literature we have see that clinical pharmacist play a crucial role in ICU Submitted: 09 October 2017 settings with reducing in mortality rate and improving some clinical outcomes. Approved: 01 November 2017 Published: 02 November 2017 Copyright: 2017 Luisetto M, et al. This is Introduction an open access article distributed under the Creative Commons Attribution License, which In ICU settings we can easily observe that the mortality rate is higher then other permits unrestricted use, distribution, and wards and for this reason a real multisiciplinatity medical team with added clinical ph. reproduction in any medium, provided the Competences can improve this situation. High intensity of cure, polipharmacy, critical original work is properly cited. patient conditions need also a pharmaceutical competencies to be added to the classic Keywords: ICU; Clinical pharmacy; Pharmaceutical decision making systems (clinical- managerial). The critically hill patients need a more care; Clinical outcomes; Mortality rate rational decision making systems to improve the clinical outcomes and in safety way. Material and Methods In this review and research paper we have searched some relevant biomedical literature in order to evaluate the real eficacy of clinical pharmacist in improving clinical outcomes and reducing mortality rate.
    [Show full text]
  • PRIMARY CARE SECTOR OVERVIEW June 2016
    PRIMARY CARE SECTOR OVERVIEW June 2016 Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams & Co. Ltd, which is and regulated by the Financial Conduct Authority. Harris Williams & Co. is a trade name under which Harris Williams LLC and Harris Williams & Co. Ltd conduct business. TABLE OF CONTENTS I PRIMARY CARE SECTOR OVERVIEW II APPENDIX: SELECT MARKET PARTICIPANTS PRIMARY CARE SECTOR OVERVIEW The delivery and coordination of primary care is taking on renewed and increasing importance as the system’s gatekeeper in the evolving U.S. healthcare landscape. Primary care accounts for nearly $250 billion of annual industry revenue and over 55% of total office-based physician visits1,2 . However, the systematic under-investment of this integral component of the healthcare system has created a number of well publicized challenges, including: • Insufficient supply of new primary care physicians from medical school • Lower compensation vis-à-vis other specialties • Demands of an aging population outstripping system resources • Under-supply of primary care to rural areas . As the initial contact point for patients, the primary care system will increasingly function as the gatekeeper for care coordination and patient referrals for public and private payors and for healthcare systems . Therefore primary care now fills a critical role in the transition from fee-for-service (“FFS”) to value-based care . To meet these challenges new, innovative primary care practice models have emerged to address care coordination, access and quality of care, and cost, including the following four models highlighted in this report: • Medicare Advantage/Managed Medicaid • Employer Sponsored Health Clinics • Retail Clinics • Concierge Clinics .
    [Show full text]
  • Introduction to Hospital and Health-System Pharmacy Practice 59 Tients with a Specific Disease State Or for Activities Related to Self Governance Diagnosis
    Part II: Managing Medication Use CHAPTER 4 Medication Management Kathy A. Chase ■■ ■■■ Key Terms and Definitions Learning Objectives ■■ Closed formulary: A list of medica- After completing this chapter, readers tions (formulary) which limits access should be able to: of a practitioner to some medications. 1. Describe the purpose of a formulary A closed formulary may limit drugs to system in managing medication use in specific physicians, patient care areas, or institutions. disease states via formulary restrictions. 2. Discuss the organization and role of the ■■ Drug formulary: A formulary is a pharmacy and therapeutics committee. continually updated list of medications 3. Explain how formulary management and related information, representing works. the clinical judgment of pharmacists, 4. List the principles of a sound formulary physicians, and other experts in the system. diagnosis and/or treatment of disease 5. Define key terms in formulary manage- and promotion of health. ment. ■■ Drug monograph: A written, unbi- ased evaluation of a specific medica- tion. This document includes the drug name, therapeutic class, pharmacology, indications for use, summary of clinical trials, pharmacokinetics/dynamics, ad- verse effects, drug interactions, dosage regimens, and cost. ■■ Drug therapy guidelines: A document describing the indications, dosage regi- mens, duration of therapy, mode(s) of administration, monitoring parameters and special considerations for use of a specific medication or medication class. ■■ Drug use evaluation (DUE): A process used to assess the appropriate- ness of drug therapy by engaging in the evaluation of data on drug use in a given health care environment against predetermined criteria and standards. ◆■ Diagnosis-related DUE: A drug use evaluation completed on pa- INTRODUCTION TO HOSPITAL AND HEALTH-SYSTEM PHARMACY PRACTICE 59 tients with a specific disease state or for activities related to self governance diagnosis.
    [Show full text]